US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anaptysbio Inc

21.82

+0.64003.02%

Volume:290.18K

Turnover:6.35M

Market Cap:669.15M

PE:-4.26

High:22.45

Open:21.05

Low:21.05

Close:21.18

Loading ...

Overview Company News Filings

AnaptysBio (ANAB) Surges 30.5%: Is This an Indication of Further Gains?

AnaptysBio price target raised to $22 from $19 at H.C. Wainwright

BUZZ-AnaptysBio climbs on arthritis drug trial data

Truist says AnaptysBio handing of placebo ‘raise doubt’ about Phase 2 RA data

AnaptysBio Shares Surge 37% After Mid-Stage Rheumatoid Arthritis Trial Meets Primary Goal

AnaptysBio's Rheumatorid Arthritis Drug Meets Primary Endpoint in Phase 2 Trial; Shares Rise

MT Newswires Live

BRIEF-Anaptys Announces Rosnilimab Achieved Positive Results In RA Phase 2B Trial

AnaptysBio Inc - Rosinilimab Safe and Well Tolerated With Similar Adverse Event Rates VS Placebo

THOMSON REUTERS

AnaptysBio Inc - Rosinilimab Achieves Statistical Significance on Key Secondary Endpoints at Week 12

THOMSON REUTERS

AnaptysBio Inc - Top-Line Week 12 Phase 2 Ulcerative Colitis Data for Rosnilimab Expected in Q4 2025

THOMSON REUTERS

Anaptys Announces Rosnilimab Achieved Positive Results in Ra Phase 2B Trial and Highest Ever Reported Cdai Lda Response Over 6 Months

THOMSON REUTERS

BRIEF-Anaptys To Announce Top-Line Data From Phase 2B Trial Of Rosnilimab, A PD-1 Depleter And Agonist, In Rheumatoid Arthritis

Anaptys to Announce Top-Line Data From Phase 2B Trial of Rosnilimab, a Pd-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025

THOMSON REUTERS

Wedbush Sticks to Its Buy Rating for AnaptysBio (ANAB)

Shareholders in AnaptysBio (NASDAQ:ANAB) are in the red if they invested three years ago

Simply Wall St.

AnaptysBio Initiated at Outperform by Wolfe Research

Truist Securities Initiates Coverage on AnaptysBio With Outperform Rating, $25 Price Target

MT Newswires Live

AnaptysBio initiated with an Outperform at Wolfe Research

Anaptys to Present at the Guggenheim SMID Cap Biotech Conference

Vanda Pharmaceuticals, AnaptysBio Sign Global License Agreement for Imsidolimab

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ANAB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANAB\",,,,,undefined,":{"symbol":"ANAB","market":"US","secType":"STK","nameCN":"Anaptysbio Inc","latestPrice":21.82,"timestamp":1746036605342,"preClose":21.18,"halted":0,"volume":290176,"delay":0,"floatShares":18032376,"shares":30666781,"eps":-5.11701,"marketStatus":"Trading","change":0.64,"latestTime":"04-30 14:10:14 EDT","open":21.05,"high":22.45,"low":21.05,"amount":6352682.43264,"amplitude":0.0661,"askPrice":21.89,"askSize":1,"bidPrice":21.73,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-5.11701,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1485406800000,"exchange":"NASDAQ","adjPreClose":21.18,"preHourTrading":{"tag":"盘前","latestPrice":21.04,"preClose":21.18,"latestTime":"09:29 EDT","volume":255,"amount":5342.12046,"timestamp":1746019799999},"postHourTrading":{"tag":"盘后","latestPrice":21.18,"preClose":21.18,"latestTime":"16:38 EDT","volume":53712,"amount":1137620.16,"timestamp":1745959101841},"volumeRatio":0.874058,"impliedVol":1.02,"impliedVolPercentile":0.532},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANAB\",,,,,undefined,":{"symbol":"ANAB","floatShares":18032376,"roa":"-15.35%","roe":"-182.71%","lyrEps":-5.11701,"volumeRatio":0.874058,"shares":30666781,"dividePrice":0,"high":22.45,"amplitude":0.0661,"preClose":21.18,"low":21.05,"week52Low":12.21,"pbRate":"9.44","psRate":"7.33","week52High":41.3083,"institutionHeld":0,"latestPrice":21.82,"committee":0.99005,"eps":-5.11701,"divideRate":0,"volume":290176,"delay":0,"ttmEps":-5.11701,"open":21.05,"prevYearClose":13.24,"prevWeekClose":20.7,"prevMonthClose":18.59,"prevQuarterClose":18.59,"fiveDayClose":20.42,"twentyDayClose":18.4,"sixtyDayClose":16.66},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANAB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511413525","title":"AnaptysBio (ANAB) Surges 30.5%: Is This an Indication of Further Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511413525","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511413525?lang=en_us&edition=fundamental","pubTime":"2025-02-13 18:11","pubTimestamp":1739441460,"startTime":"0","endTime":"0","summary":"AnaptysBio, Inc.  shares rallied 30.5% in the last trading session to close at $16.15. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 17% loss over the past four weeks.The stock price soared after AnaptysBio announced meeting the primary endpoint in a mid-stage study of its investigational candidate, rosnilimab, for moderate-to-severe rheumatoid arthritis  across all three doses compared to placebo, at week 12. Rosnilimab is a depleter and agonist of PD-1+ T cells. Per the data readout, the candidate achieved statistical significance with at least one dose and numerical superiority at all doses. The phase IIb RENOIR study also achieved certain key secondary endpoints at Week 12, with the highest recorded responses at Week 14 despite higher-than-usual placebo rates. Rosnilimab was generally safe and overall well-tolerated in the study. ANAB expects to share full 28-week data from the RA ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anaptysbio-anab-surges-30-5-101100919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANAB","BK4139","BK4007","RA","PCRX"],"gpt_icon":0},{"id":"2511588614","title":"AnaptysBio price target raised to $22 from $19 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2511588614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511588614?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:35","pubTimestamp":1739381707,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar raised the firm’s price target on AnaptysBio (ANAB) to $22 from $19 and keeps a Neutral rating on the shares a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anaptysbio-price-target-raised-to-22-from-19-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anaptysbio-price-target-raised-to-22-from-19-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2510309887","title":"BUZZ-AnaptysBio climbs on arthritis drug trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2510309887","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510309887?lang=en_us&edition=fundamental","pubTime":"2025-02-12 23:42","pubTimestamp":1739374924,"startTime":"0","endTime":"0","summary":"BUZZ-AnaptysBio climbs on arthritis drug trial data ** Shares of drug developer AnaptysBio ANAB.O surge 28.3% to $15.88 in morning trade  ** Co says its experimental drug, rosnilimab, met the main goa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL4N3P31A2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2510930652","title":"Truist says AnaptysBio handing of placebo ‘raise doubt’ about Phase 2 RA data","url":"https://stock-news.laohu8.com/highlight/detail?id=2510930652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510930652?lang=en_us&edition=fundamental","pubTime":"2025-02-12 23:00","pubTimestamp":1739372432,"startTime":"0","endTime":"0","summary":"Truist notes that AnaptysBio (ANAB) reported the “much anticipated” results of its Phase 2b trial of rosnilimab for moderate-to-severe rheumatoid a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/truist-says-anaptysbio-handing-of-placebo-raise-doubt-about-phase-2-ra-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/truist-says-anaptysbio-handing-of-placebo-raise-doubt-about-phase-2-ra-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2510374183","title":"AnaptysBio Shares Surge 37% After Mid-Stage Rheumatoid Arthritis Trial Meets Primary Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2510374183","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510374183?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:21","pubTimestamp":1739366460,"startTime":"0","endTime":"0","summary":"AnaptysBio shares surged 37% in premarket trading Wednesday after a mid-stage trial evaluating a rheumatoid arthritis treatment achieved its primary endpoint.Shares were recently trading around $17. The stock is down about 44% over the last year.AnaptysBio said the phase 2b study of rosnilimab in patients with moderate-to-severe rheumatoid arthritis on background conventional disease-modifying antirheumatic drugs met its main goal of lowering disease activity at week 12 in all three doses of the drug.The clinical stage biotechnology company said rosnilimab achieved statistical significance in at least one dose and numerical superiority at all doses on key secondary endpoints at week 12, even though higher than typical placebo rates were observed.AnaptysBio added that data across all doses showed immunological impact with robust on-target pharmacological activity in patients under treatment that was not observed for those on placebo.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SSI","ANAB"],"gpt_icon":0},{"id":"2510371500","title":"AnaptysBio's Rheumatorid Arthritis Drug Meets Primary Endpoint in Phase 2 Trial; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2510371500","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510371500?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:20","pubTimestamp":1739366416,"startTime":"0","endTime":"0","summary":"AnaptysBio  said Wednesday that a phase 2b trial of its investigational drug rosnilimab to treat moderate-to-severe rheumatoid arthritis achieved its primary and secondary endpoints.Patients in the study received either 100 milligram or 400 milligram doses of rosnilimab every four weeks, 600 milligrams every two weeks, or placebo, the company said.The trial achieved its primary endpoint of a change from baseline for all three doses vs. placebo at week 12 and showed that the drug was safe and well-tolerated, the company said.AnaptysBio shares were 23% higher in premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2510376872","title":"BRIEF-Anaptys Announces Rosnilimab Achieved Positive Results In RA Phase 2B Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376872","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510376872?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:44","pubTimestamp":1739364248,"startTime":"0","endTime":"0","summary":"BRIEF-Anaptys Announces Rosnilimab Achieved Positive Results In RA Phase 2B Trial Feb 12 (Reuters) - AnaptysBio ANAB.O:ANAPTYS ANNOUNCES ROSNILIMAB ACHIEVED POSITIVE RESULTS IN RA PHASE 2B TRIAL AND H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA1XJMV2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2510755753","title":"AnaptysBio Inc - Rosinilimab Safe and Well Tolerated With Similar Adverse Event Rates VS Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2510755753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510755753?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:30","pubTimestamp":1739363405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA1XJMV2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2510375573","title":"AnaptysBio Inc - Rosinilimab Achieves Statistical Significance on Key Secondary Endpoints at Week 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2510375573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510375573?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:30","pubTimestamp":1739363405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA1XJMV2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2510375572","title":"AnaptysBio Inc - Top-Line Week 12 Phase 2 Ulcerative Colitis Data for Rosnilimab Expected in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510375572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510375572?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:30","pubTimestamp":1739363405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA1XJMV2:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2510375504","title":"Anaptys Announces Rosnilimab Achieved Positive Results in Ra Phase 2B Trial and Highest Ever Reported Cdai Lda Response Over 6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2510375504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510375504?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:30","pubTimestamp":1739363405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA1XJMV2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2510923366","title":"BRIEF-Anaptys To Announce Top-Line Data From Phase 2B Trial Of Rosnilimab, A PD-1 Depleter And Agonist, In Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2510923366","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510923366?lang=en_us&edition=fundamental","pubTime":"2025-02-12 06:47","pubTimestamp":1739314070,"startTime":"0","endTime":"0","summary":"BRIEF-Anaptys To Announce Top-Line Data From Phase 2B Trial Of Rosnilimab, A PD-1 Depleter And Agonist, In Rheumatoid Arthritis Feb 11 (Reuters) - AnaptysBio Inc ANAB.O:ANAPTYS TO ANNOUNCE TOP-LINE DA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nTUA3C82GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2510659423","title":"Anaptys to Announce Top-Line Data From Phase 2B Trial of Rosnilimab, a Pd-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510659423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510659423?lang=en_us&edition=fundamental","pubTime":"2025-02-12 06:30","pubTimestamp":1739313000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nTUA3C82GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2509745047","title":"Wedbush Sticks to Its Buy Rating for AnaptysBio (ANAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2509745047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509745047?lang=en_us&edition=fundamental","pubTime":"2025-02-07 21:37","pubTimestamp":1738935434,"startTime":"0","endTime":"0","summary":"Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-its-buy-rating-for-anaptysbio-anab?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-its-buy-rating-for-anaptysbio-anab?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANAB"],"gpt_icon":0},{"id":"2509281219","title":"Shareholders in AnaptysBio (NASDAQ:ANAB) are in the red if they invested three years ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2509281219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509281219?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:03","pubTimestamp":1738764213,"startTime":"0","endTime":"0","summary":"AnaptysBio, Inc.  shareholders should be happy to see the share price up 13% in the last month. But that cannot eclipse the less-than-impressive returns over the last three years. In fact, the share price is down 47% in the last three years, falling well short of the market return.With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.Over the last three years, AnaptysBio's revenue dropped 43% per year. That means its revenue trend is very weak compared to other loss making companies. On the face of it we'd posit the share price fall of 14% compound, over three years is well justified by the fundamental deterioration. It would probably be worth asking whether the company can fund itself to profitability. The company will need to return to revenue growth as quickly as possible, if it wants to see some enthusiasm from investors.Please note, the market returns quoted in this article re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shareholders-anaptysbio-nasdaq-anab-red-140333281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4139","MNQmain","LU2210149790.SGD","ANAB","USJW.SI","BK4112","NDAQ","IE00B3QW5Z07.USD","QLD","LU2095319765.USD","BK4585","IE00BGHQF748.EUR",".IXIC","USAW.SI","IE00B64PRP62.GBP","PSQ","TQQQ","NVIW.SI","IE00BKPKM429.USD","LU2210150020.SGD","TSYW.SI","QID","NQmain","SQQQ"],"gpt_icon":1},{"id":"2509228467","title":"AnaptysBio Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2509228467","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509228467?lang=en_us&edition=fundamental","pubTime":"2025-02-05 02:04","pubTimestamp":1738692240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANAB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2025 13:04 ET (18:04 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB"],"gpt_icon":0},{"id":"2508453356","title":"Truist Securities Initiates Coverage on AnaptysBio With Outperform Rating, $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2508453356","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508453356?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:21","pubTimestamp":1738671719,"startTime":"0","endTime":"0","summary":"AnaptysBio (ANAB) has an average rating of overweight and mean price target of $33.09, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANAB"],"gpt_icon":0},{"id":"2508175505","title":"AnaptysBio initiated with an Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2508175505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508175505?lang=en_us&edition=fundamental","pubTime":"2025-02-04 05:35","pubTimestamp":1738618516,"startTime":"0","endTime":"0","summary":"Wolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating. Published first on TheFly – the ultimate source...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anaptysbio-initiated-with-an-outperform-at-wolfe-research?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anaptysbio-initiated-with-an-outperform-at-wolfe-research?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2508178097","title":"Anaptys to Present at the Guggenheim SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2508178097","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508178097?lang=en_us&edition=fundamental","pubTime":"2025-02-04 05:15","pubTimestamp":1738617300,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb. 03, 2025  -- AnaptysBio, Inc. , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, will present at the Guggenheim SMID Cap Biotech Conference on Wednesday, Feb. 5, 2025 at 1:00pm ET / 10:00am PT.Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. Its lead program, rosnilimab, a depleter and agonist targeting PD-1+ T cells, is in a Phase 2b trial for the treatment of rheumatoid arthritis and in a Phase 2 trial for the treatment of ulcerative colitis. Other antibodies in its portfolio include ANB033, an anti-CD122 antagonist, in a Phase 1 trial and ANB101, a BDCA2 modulator, soon to enter clinical development. Anaptys has also discovered multiple therapeutic antibodies licensed to GSK in a financial collaboration for immuno-oncology, including an an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anaptys-present-guggenheim-smid-cap-211500699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANAB","SMID","BK4011","BK4139"],"gpt_icon":0},{"id":"2508143879","title":"Vanda Pharmaceuticals, AnaptysBio Sign Global License Agreement for Imsidolimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2508143879","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508143879?lang=en_us&edition=fundamental","pubTime":"2025-02-03 21:36","pubTimestamp":1738589775,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals  and AnaptysBio  said Monday that they signed an agreement providing Vanda an exclusive global license to develop, manufacture, and commercialize imsidolimab.As part of the agreement, Vanda will make an upfront payment of $10 million and an additional $5 million for the existing drug supply to AnaptysBio, which is also eligible for up to $35 million in milestone payments and a 10% royalty on net sales, according to a joint statement.Two phase 3 trials assessing the safety and efficacy of imsidolimab in generalized pustular psoriasis have been completed, the companies said.Vanda plans to complete technology transfer activities in 2025, the companies added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ANAB","VNDA"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":121,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"ANAB","fiscalQuarterEnding":"2024/12","expectedEps":-1.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.72},{"market":"US","date":"2024-11-05","symbol":"ANAB","fiscalQuarterEnding":"2024/09","expectedEps":-1.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2024-08-05","symbol":"ANAB","fiscalQuarterEnding":"2024/06","expectedEps":-1.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":-1.71},{"market":"US","date":"2024-05-09","symbol":"ANAB","fiscalQuarterEnding":"2024/03","expectedEps":-1.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-1.64},{"market":"US","date":"2024-03-11","symbol":"ANAB","fiscalQuarterEnding":"2023/12","expectedEps":-1.74,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710129600000,"reportTimeType":"post","actualEps":-1.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANAB","date":"2025-04-29","current":-4.504014,"percent":0.614438,"low":-107.113838,"twenty":-9.868611,"median":-5.68837,"eighty":-3.597027,"high":122.514739,"avg":-4.04202,"sd":35.046768,"marketCap":654122438},"quantilePoints":[{"date":"2020-05-01","current":-4.282016,"twenty":-102.360822,"median":-47.630719,"eighty":-14.279153,"marketCap":416794317},{"date":"2020-05-08","current":-5.963603,"twenty":-102.21688,"median":-47.27063,"eighty":-13.927156,"marketCap":498080119},{"date":"2020-05-15","current":-6.146495,"twenty":-101.627764,"median":-47.210801,"eighty":-13.673774,"marketCap":513355304},{"date":"2020-05-22","current":-6.489419,"twenty":-101.315349,"median":-46.829498,"eighty":-13.329309,"marketCap":541996275},{"date":"2020-05-29","current":-6.23141,"twenty":-101.145154,"median":-46.635721,"eighty":-13.216999,"marketCap":520447354},{"date":"2020-06-05","current":-6.348984,"twenty":-100.994275,"median":-46.353129,"eighty":-12.915679,"marketCap":530267115},{"date":"2020-06-12","current":-6.051783,"twenty":-98.863273,"median":-46.2545,"eighty":-12.812956,"marketCap":505444940},{"date":"2020-06-19","current":-7.299372,"twenty":-97.282542,"median":-46.094759,"eighty":-12.682841,"marketCap":609643520},{"date":"2020-06-26","current":-7.394084,"twenty":-97.172002,"median":-45.973649,"eighty":-12.319887,"marketCap":617553883},{"date":"2020-07-02","current":-7.361424,"twenty":-97.09082,"median":-45.865995,"eighty":-11.997337,"marketCap":614826172},{"date":"2020-07-10","current":-6.936853,"twenty":-97.060378,"median":-44.893241,"eighty":-11.604251,"marketCap":579365922},{"date":"2020-07-17","current":-7.165468,"twenty":-96.641788,"median":-44.6818,"eighty":-11.333063,"marketCap":598459903},{"date":"2020-07-24","current":-6.329388,"twenty":-96.23563,"median":-44.446908,"eighty":-7.578936,"marketCap":528630488},{"date":"2020-07-31","current":-5.865625,"twenty":-96.022508,"median":-44.084321,"eighty":-7.405188,"marketCap":489896985},{"date":"2020-08-07","current":-6.028922,"twenty":-95.657006,"median":-43.867463,"eighty":-7.356853,"marketCap":503535542},{"date":"2020-08-14","current":-5.692594,"twenty":-95.382396,"median":-42.906555,"eighty":-7.249729,"marketCap":461703554},{"date":"2020-08-21","current":-5.877747,"twenty":-95.112918,"median":-41.814068,"eighty":-7.011969,"marketCap":476720524},{"date":"2020-08-28","current":-5.699327,"twenty":-95.051072,"median":-39.751195,"eighty":-6.757879,"marketCap":462249626},{"date":"2020-09-04","current":-5.372786,"twenty":-94.731497,"median":-38.336331,"eighty":-6.608299,"marketCap":435765152},{"date":"2020-09-11","current":-4.861092,"twenty":-94.485965,"median":-38.193546,"eighty":-6.504443,"marketCap":394263709},{"date":"2020-09-18","current":-5.413183,"twenty":-94.353581,"median":-37.928746,"eighty":-6.445002,"marketCap":439041582},{"date":"2020-09-25","current":-4.914954,"twenty":-94.257075,"median":-37.663945,"eighty":-6.339839,"marketCap":398632282},{"date":"2020-10-02","current":-5.254961,"twenty":-94.147431,"median":-37.419914,"eighty":-6.285625,"marketCap":426208899},{"date":"2020-10-09","current":-5.669029,"twenty":-93.735088,"median":-37.248573,"eighty":-6.226184,"marketCap":459792304},{"date":"2020-10-16","current":-8.106308,"twenty":-93.464568,"median":-37.17069,"eighty":-6.218346,"marketCap":657470230},{"date":"2020-10-23","current":-8.661765,"twenty":-93.420761,"median":-36.981177,"eighty":-6.226184,"marketCap":702521139},{"date":"2020-10-30","current":-9.917435,"twenty":-93.389294,"median":-36.765701,"eighty":-6.258844,"marketCap":804363496},{"date":"2020-11-06","current":-10.703569,"twenty":-93.320185,"median":-36.625513,"eighty":-6.279093,"marketCap":790351564},{"date":"2020-11-13","current":-10.833197,"twenty":-93.225065,"median":-36.407442,"eighty":-6.282359,"marketCap":799923296},{"date":"2020-11-20","current":-9.799877,"twenty":-93.102802,"median":-36.282831,"eighty":-6.285625,"marketCap":723622920},{"date":"2020-11-27","current":-9.551732,"twenty":-92.960679,"median":-36.101104,"eighty":-6.301301,"marketCap":705299890},{"date":"2020-12-04","current":-8.948036,"twenty":-92.81426,"median":-36.038799,"eighty":-6.325469,"marketCap":660722968},{"date":"2020-12-11","current":-8.503597,"twenty":-92.686841,"median":-35.89861,"eighty":-6.332001,"marketCap":627905602},{"date":"2020-12-18","current":-8.444338,"twenty":-92.396892,"median":-35.768806,"eighty":-6.338533,"marketCap":623529954},{"date":"2020-12-24","current":-8.240637,"twenty":-92.182886,"median":-35.701308,"eighty":-6.343758,"marketCap":608488661},{"date":"2020-12-31","current":-7.962863,"twenty":-92.182886,"median":-35.545543,"eighty":-6.348984,"marketCap":587977807},{"date":"2021-01-08","current":-9.385067,"twenty":-92.14863,"median":-35.379395,"eighty":-6.375111,"marketCap":692993378},{"date":"2021-01-15","current":-9.670249,"twenty":-91.985291,"median":-35.202861,"eighty":-6.417568,"marketCap":714051188},{"date":"2021-01-22","current":-9.459141,"twenty":-91.677485,"median":-35.031519,"eighty":-6.454146,"marketCap":698462939},{"date":"2021-01-29","current":-9.59988,"twenty":-91.490915,"median":-34.996265,"eighty":-6.484193,"marketCap":708855105},{"date":"2021-02-05","current":-10.818383,"twenty":-91.299081,"median":-34.753062,"eighty":-6.494645,"marketCap":798829384},{"date":"2021-02-12","current":-13.047984,"twenty":-90.952994,"median":-34.388024,"eighty":-6.501177,"marketCap":963463170},{"date":"2021-02-19","current":-10.803568,"twenty":-90.787654,"median":-34.236956,"eighty":-6.504443,"marketCap":797735471},{"date":"2021-02-26","current":-39.391762,"twenty":-90.593908,"median":-34.17968,"eighty":-6.552778,"marketCap":785117200},{"date":"2021-03-05","current":-40.448614,"twenty":-90.442681,"median":-34.388024,"eighty":-6.586091,"marketCap":806181320},{"date":"2021-03-12","current":-29.303628,"twenty":-90.369262,"median":-34.17968,"eighty":-6.603074,"marketCap":584050600},{"date":"2021-03-19","current":-29.536959,"twenty":-90.271614,"median":-33.938275,"eighty":-6.631161,"marketCap":588701120},{"date":"2021-03-26","current":-29.111473,"twenty":-90.167815,"median":-33.911537,"eighty":-6.668392,"marketCap":580220760},{"date":"2021-04-01","current":-29.907543,"twenty":-90.10307,"median":-33.764632,"eighty":-6.704971,"marketCap":596087240},{"date":"2021-04-09","current":-28.644811,"twenty":-90.056712,"median":-33.686999,"eighty":-6.746122,"marketCap":570919720},{"date":"2021-04-16","current":-29.811466,"twenty":-90.014454,"median":-33.14234,"eighty":-6.787273,"marketCap":594172320},{"date":"2021-04-23","current":-32.405557,"twenty":-89.896866,"median":-33.041179,"eighty":-6.836475,"marketCap":645875160},{"date":"2021-04-30","current":-32.062001,"twenty":-89.76979,"median":-33.064374,"eighty":-6.889164,"marketCap":639027739},{"date":"2021-05-07","current":-24.000343,"twenty":-89.659439,"median":-32.847073,"eighty":-6.966899,"marketCap":715978245},{"date":"2021-05-14","current":-23.945297,"twenty":-89.433486,"median":-32.643367,"eighty":-7.011969,"marketCap":714336093},{"date":"2021-05-21","current":-23.275562,"twenty":-89.177361,"median":-32.526722,"eighty":-7.062918,"marketCap":694356578},{"date":"2021-05-28","current":-21.899396,"twenty":-89.117329,"median":-32.389503,"eighty":-7.149792,"marketCap":653302780},{"date":"2021-06-04","current":-20.917731,"twenty":-89.095065,"median":-32.165446,"eighty":-7.176572,"marketCap":624017737},{"date":"2021-06-11","current":-22.275548,"twenty":-88.971253,"median":-32.153771,"eighty":-7.228174,"marketCap":664524151},{"date":"2021-06-18","current":-22.32142,"twenty":-88.710958,"median":-32.066795,"eighty":-7.264752,"marketCap":665892611},{"date":"2021-06-25","current":-24.257228,"twenty":-88.62939,"median":-32.017847,"eighty":-7.296759,"marketCap":723641621},{"date":"2021-07-02","current":-23.706761,"twenty":-88.61741,"median":-31.951807,"eighty":-7.309823,"marketCap":707220102},{"date":"2021-07-09","current":-23.844378,"twenty":-88.596554,"median":-31.869492,"eighty":-7.351627,"marketCap":711325482},{"date":"2021-07-16","current":-23.917773,"twenty":-88.277702,"median":-31.584142,"eighty":-7.358159,"marketCap":713515017},{"date":"2021-07-23","current":-23.624191,"twenty":-88.225176,"median":-31.44408,"eighty":-7.361424,"marketCap":704756874},{"date":"2021-07-30","current":-21.082871,"twenty":-88.03791,"median":-31.365362,"eighty":-7.385897,"marketCap":628944193},{"date":"2021-08-06","current":-21.541593,"twenty":-87.661094,"median":-31.129099,"eighty":-7.394084,"marketCap":642628792},{"date":"2021-08-13","current":-74.211439,"twenty":-87.540211,"median":-31.365362,"eighty":-7.39735,"marketCap":646604271},{"date":"2021-08-20","current":-76.289486,"twenty":-87.471939,"median":-31.44408,"eighty":-7.407148,"marketCap":664710288},{"date":"2021-08-27","current":-79.815867,"twenty":-87.455558,"median":-31.584142,"eighty":-7.433275,"marketCap":695435650},{"date":"2021-09-03","current":-84.381272,"twenty":-87.202721,"median":-31.869492,"eighty":-7.514924,"marketCap":735214021},{"date":"2021-09-10","current":-81.264202,"twenty":-87.130943,"median":-31.951807,"eighty":-7.5306,"marketCap":708054995},{"date":"2021-09-17","current":-84.759098,"twenty":-87.082688,"median":-32.017847,"eighty":-7.578936,"marketCap":738506024},{"date":"2021-09-24","current":-86.081491,"twenty":-87.130943,"median":-32.066795,"eighty":-7.788609,"marketCap":750028035},{"date":"2021-10-01","current":-86.86863,"twenty":-87.082688,"median":-32.153771,"eighty":-7.937941,"marketCap":756886374},{"date":"2021-10-08","current":-88.253994,"twenty":-87.130943,"median":-32.165446,"eighty":-7.989529,"marketCap":768957052},{"date":"2021-10-15","current":-90.269069,"twenty":-87.485593,"median":-32.39753,"eighty":-8.034714,"marketCap":786514402},{"date":"2021-10-22","current":-89.891243,"twenty":-87.736457,"median":-32.53832,"eighty":-8.09175,"marketCap":783222399},{"date":"2021-10-29","current":-103.587457,"twenty":-88.310743,"median":-32.676995,"eighty":-8.105767,"marketCap":902557511},{"date":"2021-11-05","current":121.206519,"twenty":-88.498825,"median":-32.710623,"eighty":-8.09175,"marketCap":1016680284},{"date":"2021-11-12","current":107.401579,"twenty":-88.449205,"median":-32.590843,"eighty":-7.788609,"marketCap":900884445},{"date":"2021-11-19","current":101.006676,"twenty":-88.310743,"median":-32.405557,"eighty":-7.42805,"marketCap":847243997},{"date":"2021-11-26","current":102.056096,"twenty":-88.263477,"median":-32.300442,"eighty":-7.390809,"marketCap":856046532},{"date":"2021-12-03","current":99.039013,"twenty":-88.236703,"median":-32.158148,"eighty":-7.330725,"marketCap":830739244},{"date":"2021-12-10","current":98.383126,"twenty":-88.112816,"median":-32.108332,"eighty":-7.198781,"marketCap":825237660},{"date":"2021-12-17","current":116.616799,"twenty":-87.81182,"median":-32.063805,"eighty":-6.981923,"marketCap":978181706},{"date":"2021-12-23","current":121.568749,"twenty":-87.64637,"median":-31.965725,"eighty":-6.787273,"marketCap":1019718668},{"date":"2021-12-31","current":114.527209,"twenty":-87.590654,"median":-31.886153,"eighty":-6.625282,"marketCap":960654228},{"date":"2022-01-07","current":107.968672,"twenty":-87.512902,"median":-31.744362,"eighty":-6.503789,"marketCap":905641223},{"date":"2022-01-14","current":111.198504,"twenty":-87.465387,"median":-31.474719,"eighty":-6.435857,"marketCap":932733055},{"date":"2022-01-21","current":102.1352,"twenty":-87.404991,"median":-31.433351,"eighty":-6.343758,"marketCap":856710058},{"date":"2022-01-28","current":103.090967,"twenty":-87.082688,"median":-31.139961,"eighty":-6.286278,"marketCap":864727029},{"date":"2022-02-04","current":103.387584,"twenty":-86.659797,"median":-30.807233,"eighty":-6.218346,"marketCap":867215054},{"date":"2022-02-11","current":98.839453,"twenty":-86.123364,"median":-30.46627,"eighty":-6.096853,"marketCap":829065332},{"date":"2022-02-18","current":98.872411,"twenty":-85.686428,"median":-30.19227,"eighty":-6.039372,"marketCap":829341780},{"date":"2022-02-25","current":103.585329,"twenty":-85.389506,"median":-29.908779,"eighty":-5.981432,"marketCap":868873738},{"date":"2022-03-04","current":99.696347,"twenty":-85.044783,"median":-29.616083,"eighty":-5.941808,"marketCap":836252961},{"date":"2022-03-11","current":-13.694174,"twenty":-84.849106,"median":-29.457961,"eighty":-5.941808,"marketCap":791468505},{"date":"2022-03-18","current":-13.171647,"twenty":-84.179764,"median":-29.293712,"eighty":-5.941808,"marketCap":761268494},{"date":"2022-03-25","current":-12.099146,"twenty":-83.207815,"median":-29.117087,"eighty":-5.941808,"marketCap":699282255},{"date":"2022-04-01","current":-11.993811,"twenty":-82.693975,"median":-28.864249,"eighty":-5.941808,"marketCap":693194321},{"date":"2022-04-08","current":-12.558789,"twenty":-82.218961,"median":-28.602291,"eighty":-5.941808,"marketCap":725847786},{"date":"2022-04-14","current":-10.945251,"twenty":-81.834485,"median":-28.440131,"eighty":-5.941808,"marketCap":632591704},{"date":"2022-04-22","current":-10.586154,"twenty":-81.257019,"median":-28.16628,"eighty":-5.941808,"marketCap":611837383},{"date":"2022-04-29","current":-11.2038,"twenty":-79.985253,"median":-27.857252,"eighty":-5.941808,"marketCap":647534815},{"date":"2022-05-06","current":-8.266576,"twenty":-79.076657,"median":-27.557745,"eighty":-5.941808,"marketCap":627333942},{"date":"2022-05-13","current":-7.848033,"twenty":-78.070148,"median":-27.087535,"eighty":-5.941808,"marketCap":595571553},{"date":"2022-05-20","current":-7.755179,"twenty":-76.645664,"median":-26.326588,"eighty":-5.941808,"marketCap":588525037},{"date":"2022-05-27","current":-7.298337,"twenty":-75.64915,"median":-24.101263,"eighty":-5.941808,"marketCap":553856177},{"date":"2022-06-03","current":-7.784892,"twenty":-74.999024,"median":-23.94071,"eighty":-5.941808,"marketCap":590779922},{"date":"2022-06-10","current":-8.171166,"twenty":-74.630316,"median":-23.844378,"eighty":-5.941808,"marketCap":620093430},{"date":"2022-06-17","current":-7.966887,"twenty":-74.313821,"median":-23.729697,"eighty":-5.941808,"marketCap":604591094},{"date":"2022-06-24","current":-8.587152,"twenty":-73.79367,"median":-23.624191,"eighty":-5.940942,"marketCap":651661822},{"date":"2022-07-01","current":-7.602898,"twenty":-73.236005,"median":-23.475818,"eighty":-5.940942,"marketCap":576968750},{"date":"2022-07-08","current":-7.547186,"twenty":-72.726873,"median":-23.119597,"eighty":-5.940942,"marketCap":572740840},{"date":"2022-07-15","current":-7.554614,"twenty":-72.028355,"median":-22.871887,"eighty":-5.940942,"marketCap":573304562},{"date":"2022-07-22","current":-7.781178,"twenty":-70.850347,"median":-22.48656,"eighty":-5.940942,"marketCap":590498061},{"date":"2022-07-29","current":-7.777464,"twenty":-69.195237,"median":-22.32142,"eighty":-5.940942,"marketCap":590216201},{"date":"2022-08-05","current":-9.170277,"twenty":-62.556885,"median":-22.15628,"eighty":-5.940942,"marketCap":695913944},{"date":"2022-08-12","current":-6.844736,"twenty":-62.060745,"median":-22.027838,"eighty":-5.940942,"marketCap":739320484},{"date":"2022-08-19","current":-6.5962,"twenty":-59.317433,"median":-21.945268,"eighty":-5.940942,"marketCap":712475318},{"date":"2022-08-26","current":-6.170048,"twenty":-57.318145,"median":-21.761779,"eighty":-5.940942,"marketCap":666445403},{"date":"2022-09-02","current":-6.494237,"twenty":-56.475572,"median":-21.611737,"eighty":-5.940942,"marketCap":701462026},{"date":"2022-09-09","current":-6.713849,"twenty":-55.356675,"median":-21.541593,"eighty":-5.940942,"marketCap":725182964},{"date":"2022-09-16","current":-6.606657,"twenty":-54.652593,"median":-21.477894,"eighty":-5.940942,"marketCap":713604887},{"date":"2022-09-23","current":-6.643259,"twenty":-53.92042,"median":-21.414909,"eighty":-5.940942,"marketCap":717558376},{"date":"2022-09-30","current":-6.669404,"twenty":-53.330905,"median":-21.182651,"eighty":-5.940942,"marketCap":720382298},{"date":"2022-10-07","current":-6.855028,"twenty":-52.739996,"median":-20.917731,"eighty":-5.940942,"marketCap":740432138},{"date":"2022-10-14","current":-6.933461,"twenty":-52.199259,"median":-20.253622,"eighty":-5.940942,"marketCap":748903902},{"date":"2022-10-21","current":-7.221048,"twenty":-51.254531,"median":-17.117041,"eighty":-5.940942,"marketCap":779967035},{"date":"2022-10-28","current":-7.55308,"twenty":-50.630173,"median":-15.497445,"eighty":-5.940942,"marketCap":815830834},{"date":"2022-11-04","current":-7.757005,"twenty":-49.841198,"median":-14.803867,"eighty":-5.940942,"marketCap":837857420},{"date":"2022-11-11","current":-6.529731,"twenty":-49.674799,"median":-14.446249,"eighty":-5.940942,"marketCap":880527643},{"date":"2022-11-18","current":-5.751729,"twenty":-49.04403,"median":-14.110688,"eighty":-5.923625,"marketCap":775614920},{"date":"2022-11-25","current":-5.93516,"twenty":-48.51213,"median":-13.957248,"eighty":-5.892149,"marketCap":800350440},{"date":"2022-12-02","current":-5.758054,"twenty":-47.764966,"median":-13.692948,"eighty":-5.859701,"marketCap":776467869},{"date":"2022-12-09","current":-5.903534,"twenty":-47.615808,"median":-13.340267,"eighty":-5.844082,"marketCap":796085696},{"date":"2022-12-16","current":-5.876125,"twenty":-47.20632,"median":-13.186182,"eighty":-5.844082,"marketCap":792389583},{"date":"2022-12-23","current":-6.162868,"twenty":-46.47424,"median":-12.915679,"eighty":-5.833129,"marketCap":831056603},{"date":"2022-12-30","current":-6.533947,"twenty":-46.256273,"median":-12.812956,"eighty":-5.833129,"marketCap":881096275},{"date":"2023-01-06","current":-4.897825,"twenty":-46.073767,"median":-12.768443,"eighty":-5.829319,"marketCap":660466811},{"date":"2023-01-13","current":-5.561973,"twenty":-44.92759,"median":-12.558789,"eighty":-5.783211,"marketCap":750026452},{"date":"2023-01-20","current":-5.271013,"twenty":-44.638657,"median":-12.412337,"eighty":-5.751729,"marketCap":710790800},{"date":"2023-01-27","current":-5.083365,"twenty":-44.055254,"median":-12.225773,"eighty":-5.700407,"marketCap":685486647},{"date":"2023-02-03","current":-5.435468,"twenty":-42.408992,"median":-12.066504,"eighty":-5.661805,"marketCap":732967472},{"date":"2023-02-10","current":-5.439685,"twenty":-40.030163,"median":-11.993811,"eighty":-5.565611,"marketCap":733536105},{"date":"2023-02-17","current":-5.690585,"twenty":-38.543535,"median":-11.845385,"eighty":-5.486597,"marketCap":767369747},{"date":"2023-02-24","current":-5.258362,"twenty":-38.190431,"median":-11.604251,"eighty":-5.471311,"marketCap":709084902},{"date":"2023-03-03","current":-5.170725,"twenty":-37.805597,"median":-11.538956,"eighty":-5.437998,"marketCap":665596397},{"date":"2023-03-10","current":-4.853929,"twenty":-37.307763,"median":-11.302931,"eighty":-5.396973,"marketCap":624817096},{"date":"2023-03-17","current":-4.730248,"twenty":-37.088654,"median":-11.014677,"eighty":-5.364706,"marketCap":608896410},{"date":"2023-03-24","current":-4.643454,"twenty":-36.653551,"median":-10.95619,"eighty":-5.306297,"marketCap":597723999},{"date":"2023-03-31","current":-4.721568,"twenty":-36.357597,"median":-10.831346,"eighty":-5.260049,"marketCap":607779169},{"date":"2023-04-06","current":-4.623926,"twenty":-36.091759,"median":-10.753708,"eighty":-5.249507,"marketCap":595210206},{"date":"2023-04-14","current":-4.730248,"twenty":-35.861227,"median":-10.6077,"eighty":-5.185412,"marketCap":608896410},{"date":"2023-04-21","current":-4.70125,"twenty":-35.63181,"median":-10.149873,"eighty":-5.136804,"marketCap":605163736},{"date":"2023-04-28","current":-4.352363,"twenty":-35.253744,"median":-9.9031,"eighty":-5.098389,"marketCap":560253557},{"date":"2023-05-05","current":-4.398309,"twenty":-35.013053,"median":-9.786914,"eighty":-4.983017,"marketCap":566167942},{"date":"2023-05-12","current":-4.081967,"twenty":-34.470661,"median":-9.603583,"eighty":-4.957371,"marketCap":558102871},{"date":"2023-05-19","current":-3.722141,"twenty":-34.090505,"median":-9.510991,"eighty":-4.897525,"marketCap":508905942},{"date":"2023-05-26","current":-3.611086,"twenty":-33.894489,"median":-9.360057,"eighty":-4.850845,"marketCap":493722153},{"date":"2023-06-02","current":-3.58009,"twenty":-33.688088,"median":-9.257292,"eighty":-4.819837,"marketCap":489484195},{"date":"2023-06-09","current":-3.549093,"twenty":-33.106266,"median":-9.148034,"eighty":-4.794041,"marketCap":485246236},{"date":"2023-06-16","current":-3.642083,"twenty":-32.766404,"median":-9.025813,"eighty":-4.756992,"marketCap":497960112},{"date":"2023-06-23","current":-3.880368,"twenty":-32.493211,"median":-8.918407,"eighty":-4.731128,"marketCap":530539417},{"date":"2023-06-30","current":-3.924925,"twenty":-32.161901,"median":-8.858113,"eighty":-4.721568,"marketCap":536631482},{"date":"2023-07-07","current":-3.901678,"twenty":-32.066795,"median":-8.722068,"eighty":-4.69336,"marketCap":533453013},{"date":"2023-07-14","current":-3.603337,"twenty":-31.951807,"median":-8.646655,"eighty":-4.671662,"marketCap":492662664},{"date":"2023-07-21","current":-3.6014,"twenty":-31.54475,"median":-8.552745,"eighty":-4.659575,"marketCap":492397791},{"date":"2023-07-28","current":-3.243003,"twenty":-31.321254,"median":-8.441462,"eighty":-4.623926,"marketCap":443396397},{"date":"2023-08-04","current":-3.702138,"twenty":-30.936353,"median":-8.351302,"eighty":-4.591378,"marketCap":506171156},{"date":"2023-08-11","current":-3.330754,"twenty":-30.573065,"median":-8.156309,"eighty":-4.57374,"marketCap":479678594},{"date":"2023-08-18","current":-3.548258,"twenty":-30.291853,"median":-8.104955,"eighty":-4.54306,"marketCap":511002376},{"date":"2023-08-25","current":-3.732583,"twenty":-29.910014,"median":-8.033302,"eighty":-4.501445,"marketCap":537547954},{"date":"2023-09-01","current":-3.627518,"twenty":-29.626581,"median":-7.964875,"eighty":-4.482485,"marketCap":522416975},{"date":"2023-09-08","current":-3.690188,"twenty":-29.516357,"median":-7.882544,"eighty":-4.473435,"marketCap":531442471},{"date":"2023-09-15","current":-3.625675,"twenty":-29.331339,"median":-7.801606,"eighty":-4.421911,"marketCap":522151519},{"date":"2023-09-22","current":-3.161175,"twenty":-29.15813,"median":-7.768178,"eighty":-4.410373,"marketCap":455256662},{"date":"2023-09-29","current":-3.317852,"twenty":-28.945556,"median":-7.725466,"eighty":-4.383798,"marketCap":477820404},{"date":"2023-10-06","current":-3.638577,"twenty":-28.662123,"median":-7.611562,"eighty":-4.375394,"marketCap":524009709},{"date":"2023-10-13","current":-3.422917,"twenty":-28.450396,"median":-7.556471,"eighty":-4.348186,"marketCap":492951383},{"date":"2023-10-20","current":-3.284673,"twenty":-28.181862,"median":-7.539758,"eighty":-4.312301,"marketCap":473042199},{"date":"2023-10-27","current":-3.12984,"twenty":-27.910364,"median":-7.514924,"eighty":-4.282957,"marketCap":450743914},{"date":"2023-11-03","current":-2.909183,"twenty":-27.625641,"median":-7.420904,"eighty":-4.264419,"marketCap":430038363},{"date":"2023-11-10","current":-2.680512,"twenty":-27.198159,"median":-7.391191,"eighty":-4.20096,"marketCap":396235903},{"date":"2023-11-17","current":-2.563655,"twenty":-26.430091,"median":-7.351627,"eighty":-4.109811,"marketCap":378962038},{"date":"2023-11-24","current":-2.569048,"twenty":-25.349793,"median":-7.298337,"eighty":-4.075111,"marketCap":379759293},{"date":"2023-12-01","current":-2.542081,"twenty":-23.954471,"median":-7.241963,"eighty":-4.038275,"marketCap":375773016},{"date":"2023-12-08","current":-2.951979,"twenty":-23.903095,"median":-7.172476,"eighty":-3.982656,"marketCap":436364422},{"date":"2023-12-14","current":-3.284571,"twenty":-23.833369,"median":-7.137386,"eighty":-3.970669,"marketCap":485528502},{"date":"2023-12-20","current":-3.597387,"twenty":-23.752633,"median":-7.120671,"eighty":-3.958023,"marketCap":531769311},{"date":"2023-12-27","current":-3.861663,"twenty":-23.624191,"median":-7.053202,"eighty":-3.944578,"marketCap":570834823},{"date":"2024-01-05","current":-3.890427,"twenty":-23.539787,"median":-7.011969,"eighty":-3.921497,"marketCap":575086851},{"date":"2024-01-12","current":-4.138523,"twenty":-23.15079,"median":-6.935157,"eighty":-3.919889,"marketCap":611760597},{"date":"2024-01-19","current":-4.258975,"twenty":-22.879227,"median":-6.855028,"eighty":-3.918726,"marketCap":629565966},{"date":"2024-01-26","current":-4.246391,"twenty":-22.543442,"median":-6.828329,"eighty":-3.919889,"marketCap":627705704},{"date":"2024-02-02","current":-4.359652,"twenty":-22.369757,"median":-6.766255,"eighty":-3.919889,"marketCap":644448066},{"date":"2024-02-09","current":-4.158299,"twenty":-22.174383,"median":-6.716463,"eighty":-3.919889,"marketCap":614683867},{"date":"2024-02-16","current":-4.09178,"twenty":-22.048022,"median":-6.682618,"eighty":-3.919889,"marketCap":604851051},{"date":"2024-02-23","current":-4.544824,"twenty":-21.965452,"median":-6.643088,"eighty":-3.919889,"marketCap":671820499},{"date":"2024-03-01","current":-4.589769,"twenty":-21.899396,"median":-6.601429,"eighty":-3.921051,"marketCap":678464294},{"date":"2024-03-08","current":-4.427968,"twenty":-21.674722,"median":-6.533947,"eighty":-3.921051,"marketCap":654546634},{"date":"2024-03-15","current":-3.860241,"twenty":-21.569116,"median":-6.496851,"eighty":-3.911364,"marketCap":631608711},{"date":"2024-03-22","current":-3.999275,"twenty":-21.509386,"median":-6.463291,"eighty":-3.891167,"marketCap":654357330},{"date":"2024-03-28","current":-3.497116,"twenty":-21.462147,"median":-6.410575,"eighty":-3.874556,"marketCap":572194671},{"date":"2024-04-05","current":-3.484031,"twenty":-21.303045,"median":-6.370546,"eighty":-3.84928,"marketCap":570053625},{"date":"2024-04-12","current":-4.045074,"twenty":-21.147222,"median":-6.326122,"eighty":-3.819153,"marketCap":661850993},{"date":"2024-04-19","current":-3.243584,"twenty":-20.54729,"median":-6.282032,"eighty":-3.800939,"marketCap":530711896},{"date":"2024-04-26","current":-3.150629,"twenty":-17.957202,"median":-6.218346,"eighty":-3.783504,"marketCap":515502812},{"date":"2024-05-03","current":-4.397858,"twenty":-16.774632,"median":-6.186061,"eighty":-3.779629,"marketCap":719573082},{"date":"2024-05-10","current":-4.379492,"twenty":-15.192701,"median":-6.170048,"eighty":-3.779629,"marketCap":716568032},{"date":"2024-05-17","current":-4.260905,"twenty":-14.607181,"median":-6.116483,"eighty":-3.779629,"marketCap":695805862},{"date":"2024-05-24","current":-4.175587,"twenty":-14.349467,"median":-6.09424,"eighty":-3.779629,"marketCap":681873354},{"date":"2024-05-31","current":-3.956436,"twenty":-14.073023,"median":-6.0707,"eighty":-3.779629,"marketCap":646085930},{"date":"2024-06-07","current":-3.999931,"twenty":-13.918938,"median":-6.040581,"eighty":-3.779629,"marketCap":653188778},{"date":"2024-06-14","current":-4.05681,"twenty":-13.616431,"median":-6.014737,"eighty":-3.776092,"marketCap":662477117},{"date":"2024-06-21","current":-3.829294,"twenty":-13.299862,"median":-5.978739,"eighty":-3.772555,"marketCap":625323761},{"date":"2024-06-28","current":-4.14882,"twenty":-13.172486,"median":-5.953176,"eighty":-3.761943,"marketCap":677502371},{"date":"2024-07-05","current":-4.16555,"twenty":-12.915679,"median":-5.936751,"eighty":-3.761943,"marketCap":680234235},{"date":"2024-07-12","current":-5.072268,"twenty":-12.812956,"median":-5.891938,"eighty":-3.761943,"marketCap":828301286},{"date":"2024-07-15","current":-5.035463,"twenty":-12.798187,"median":-5.889829,"eighty":-3.761943,"marketCap":822291184},{"date":"2024-08-02","current":-5.701282,"twenty":-12.400011,"median":-5.833983,"eighty":-3.74922,"marketCap":931019387},{"date":"2024-08-09","current":-5.419995,"twenty":-12.209595,"median":-5.803572,"eighty":-3.74922,"marketCap":922022524},{"date":"2024-08-16","current":-5.760715,"twenty":-12.056579,"median":-5.760163,"eighty":-3.74922,"marketCap":979983964},{"date":"2024-08-23","current":-6.61994,"twenty":-11.988647,"median":-5.760163,"eighty":-3.74922,"marketCap":1126151064},{"date":"2024-08-30","current":-6.500997,"twenty":-11.801336,"median":-5.760163,"eighty":-3.74922,"marketCap":1105917188},{"date":"2024-09-06","current":-6.531177,"twenty":-11.604251,"median":-5.760163,"eighty":-3.74922,"marketCap":1111051157},{"date":"2024-09-13","current":-6.799241,"twenty":-11.52938,"median":-5.760163,"eighty":-3.74922,"marketCap":1156652876},{"date":"2024-09-20","current":-6.662546,"twenty":-11.2786,"median":-5.760163,"eighty":-3.74922,"marketCap":1133399019},{"date":"2024-09-27","current":-5.771366,"twenty":-11.010233,"median":-5.758054,"eighty":-3.74922,"marketCap":981795953},{"date":"2024-10-04","current":-6.218731,"twenty":-10.962393,"median":-5.751729,"eighty":-3.74922,"marketCap":1057899484},{"date":"2024-10-11","current":-5.680828,"twenty":-10.831716,"median":-5.742962,"eighty":-3.74922,"marketCap":966394048},{"date":"2024-10-18","current":-6.24536,"twenty":-10.696822,"median":-5.742962,"eighty":-3.74922,"marketCap":1062429456},{"date":"2024-10-25","current":-5.719884,"twenty":-10.364531,"median":-5.741187,"eighty":-3.74922,"marketCap":973038007},{"date":"2024-10-31","current":-3.937524,"twenty":-10.126279,"median":-5.701282,"eighty":-3.74922,"marketCap":669831874},{"date":"2024-11-08","current":-3.947364,"twenty":-9.863426,"median":-5.683491,"eighty":-3.738421,"marketCap":653912376},{"date":"2024-11-15","current":-3.704901,"twenty":-9.863426,"median":-5.683491,"eighty":-3.75615,"marketCap":613746515},{"date":"2024-11-22","current":-3.888585,"twenty":-9.863426,"median":-5.683491,"eighty":-3.76548,"marketCap":644175197},{"date":"2024-11-29","current":-4.584746,"twenty":-9.863426,"median":-5.683491,"eighty":-3.783674,"marketCap":759499902},{"date":"2024-12-06","current":-4.345957,"twenty":-9.863426,"median":-5.683491,"eighty":-3.783674,"marketCap":719942616},{"date":"2024-12-13","current":-2.75893,"twenty":-9.863426,"median":-5.683491,"eighty":-3.780013,"marketCap":457038803},{"date":"2024-12-20","current":-2.755256,"twenty":-9.863426,"median":-5.683491,"eighty":-3.740305,"marketCap":456430230},{"date":"2024-12-27","current":-2.523815,"twenty":-9.863426,"median":-5.683491,"eighty":-3.726088,"marketCap":418090090},{"date":"2025-01-03","current":-2.454015,"twenty":-9.863426,"median":-5.683491,"eighty":-3.709281,"marketCap":406527191},{"date":"2025-01-10","current":-2.637699,"twenty":-9.863573,"median":-5.686154,"eighty":-3.702138,"marketCap":436955873},{"date":"2025-01-17","current":-2.760767,"twenty":-9.863573,"median":-5.686154,"eighty":-3.695718,"marketCap":457343090},{"date":"2025-01-24","current":-3.054661,"twenty":-9.863573,"median":-5.686154,"eighty":-3.680828,"marketCap":506028981},{"date":"2025-01-31","current":-3.199771,"twenty":-9.863573,"median":-5.686154,"eighty":-3.663153,"marketCap":530067640},{"date":"2025-02-07","current":-2.953635,"twenty":-9.863573,"median":-5.686154,"eighty":-3.638577,"marketCap":489293206},{"date":"2025-02-14","current":-3.543259,"twenty":-9.863573,"median":-5.686154,"eighty":-3.631204,"marketCap":586969275},{"date":"2025-02-21","current":-3.466112,"twenty":-9.863573,"median":-5.686154,"eighty":-3.628522,"marketCap":574189229},{"date":"2025-02-28","current":-3.436115,"twenty":-9.863573,"median":-5.686154,"eighty":-3.624647,"marketCap":499030384},{"date":"2025-03-07","current":-3.463002,"twenty":-9.868611,"median":-5.68837,"eighty":-3.614297,"marketCap":502935208},{"date":"2025-03-14","current":-3.555912,"twenty":-9.868611,"median":-5.68837,"eighty":-3.611055,"marketCap":516428592},{"date":"2025-03-21","current":-3.710057,"twenty":-9.868611,"median":-5.68837,"eighty":-3.600725,"marketCap":538815342},{"date":"2025-03-28","current":-3.938109,"twenty":-9.868611,"median":-5.68837,"eighty":-3.60191,"marketCap":571935465},{"date":"2025-04-04","current":-4.07325,"twenty":-9.868611,"median":-5.68837,"eighty":-3.60191,"marketCap":591562205},{"date":"2025-04-11","current":-3.429216,"twenty":-9.863573,"median":-5.686154,"eighty":-3.597387,"marketCap":498028523},{"date":"2025-04-17","current":-4.024684,"twenty":-9.863573,"median":-5.686154,"eighty":-3.597387,"marketCap":584508845},{"date":"2025-04-25","current":-4.35198,"twenty":-9.868611,"median":-5.68837,"eighty":-3.597027,"marketCap":632042356},{"date":"2025-04-29","current":-4.504014,"twenty":-9.868611,"median":-5.68837,"eighty":-3.597027,"marketCap":654122438}],"updateTime":1746003025527}}}